Inactive Instrument

Other languages F-star Therapeutics, Inc.

Equities

FSTX

US30315R1077

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-09-28
F-Star Entered into Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generationmulti-Specific Antibodies	23-07-05
F-Star Announces Licence Agreement with Takeda for Second Novel Next-Generation Immuno-Oncology Bispecific Antibody	23-03-22
Sino Biopharmaceutical Completes $161 Million Acquisition of F-star Therapeutics	23-03-08
InvoX Pharma Limited completed the acquisition of F-star Therapeutics, Inc.	23-03-07
F-star Therapeutics Gets Final Regulatory Nod For Acquisition by Invox Pharma	23-03-07
Top Midday Gainers	22-12-30
F-star Therapeutics Extends invoX Deal Date to Help Address CFIUS Concerns; Shares Rise	22-12-30
F-star Therapeutics Says US Regulator Blocks Merger With invoX Pharma on National Security Concern; Shares Slump	22-12-29
Top Premarket Gainers	22-12-21
F-star Therapeutics, Inc. Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress	22-12-06
Sector Update: Health Care Stocks Advance Modestly	22-11-21
Sector Update: Health Care	22-11-21
F-star Therapeutics, invoX Pharma Extend Merger Completion Date	22-11-21
F-star Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10
F-star Therapeutics, Inc. Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research	22-11-07
F-star Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11
F-star Therapeutics to Grant Takeda License for Immuno-oncology Bispecific Antibody	22-07-20
F-star Therapeutics, Inc. Announces A License Agreement with Takeda for A Novel Next-Generation Immuno-Oncology Bispecific Antibody	22-07-20
Sector Update: Health Care Stocks Lead Thursday Markets Recovery	22-06-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages F-star Therapeutics, Inc.

Equities

FSTX

US30315R1077

Other languages

Filters